Keros Therapeutics (Series B)

Funding Details
Awarder
Inbox
Date Award
January 08, 2019
Vertical
Biotechnology
Funding URL
View Funding Page
Funding Amount:
$23,000,000

Company Info
Founders
Jasbir Seehra, Ph.D.
Company Description
Keros is a clinical-stage biopharmaceutical company focusing on the discovery, development, and commercialization of novel treatments.
Market
Neuromuscular diseases
Location
Lexington, Massachusetts, USA
Coinvestors
Arkin Bio Ventures, Global Health Science Fund, Medison Pharma, Partners Innovation Fund, Pontifax

Links